XML 113 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Restructuring (Tables)
12 Months Ended
Dec. 31, 2019
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
The following table presents the accruals, inventory obsolescence and other reserves, recorded in connection with our reorganization plans including the balances and activity related to the CRM business franchise (in thousands):
 
 
Employee Severance and Other Termination Costs
 
Other
 
Total
Balance at December 31, 2016
 
$
21,092

 
$
3,056

 
$
24,148

Charges
 
10,076

 
5,363

 
15,439

Cash payments / write-downs
 
(27,279
)
 
(5,794
)
 
(33,073
)
Balance at December 31, 2017
 
3,889

 
2,625

 
6,514

Charges
 
15,641

 
925

 
16,566

Cash payments
 
(9,335
)
 
(481
)
 
(9,816
)
Balance at December 31, 2018
 
10,195

 
3,069

 
13,264

Charges
 
11,472

 
782

 
12,254

Cash payments
 
(17,570
)
 
(2,451
)
 
(20,021
)
Balance at December 31, 2019 (1)
 
$
4,097

 
$
1,400

 
$
5,497


(1)
Cumulatively, we have recognized a total of $111.5 million in restructuring expense, inclusive of discontinued operations.
Schedule of Restructuring Reserve by Type of Cost
The following table presents restructuring expense by reportable segment (in thousands):
 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Cardiovascular (1)
 
$
3,592

 
$
11,497

 
$
8,819

Neuromodulation
 
1,082

 
1,595

 
561

Other (2)
 
7,580

 
2,823

 
7,676

Restructuring expense from continuing operations
 
12,254

 
15,915

 
17,056

Discontinued operations
 

 
651

 
(1,617
)
Total
 
$
12,254

 
$
16,566

 
$
15,439

(1)
Cardiovascular restructuring expense for the year ended December 31, 2018 included $6.5 million of 2018 Plan expenses. Cardiovascular restructuring expense for the year ended December 31, 2017 included building and equipment impairment of $5.4 million related to the Suzhou, China facility exit plan.
(2)
Other restructuring expense for the year ended December 31, 2019 included $3.5 million of Caisson restructuring expenses.